CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
about
CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CXC chemokine receptor 1 predi ...... ctable gastric cancer patients
@en
CXC chemokine receptor 1 predi ...... table gastric cancer patients.
@nl
type
label
CXC chemokine receptor 1 predi ...... ctable gastric cancer patients
@en
CXC chemokine receptor 1 predi ...... table gastric cancer patients.
@nl
prefLabel
CXC chemokine receptor 1 predi ...... ctable gastric cancer patients
@en
CXC chemokine receptor 1 predi ...... table gastric cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
CXC chemokine receptor 1 predi ...... ctable gastric cancer patients
@en
P2093
Heng Zhang
Hongyong He
Ruochen Li
Songyang Wu
Weijuan Zhang
P2860
P304
20328-20339
P356
10.18632/ONCOTARGET.12815
P407
P577
2016-10-21T00:00:00Z